Syngene is an integrated research, development, and manufacturing services organization offering scientific solutions to provide advances in human and animal health, specialty chemicals, and consumer goods. We offer client partnerships that range from a single specialist service to an end-to-end program, accelerating the progress of a molecule to market through seamless integration.
Full year revenue from operations growth was 23% at Rs 3,193 Cr (USD 397 Mn)3 and profit after tax before exceptional items grew by 10% to Rs 464 Cr (USD 58 Mn), exceeding the upgraded guidance provided earlier in the year on both measures.
We signed a 10‑year partnership with Zoetis for commercial manufacturing of a monoclonal antibody for animal health and celebrated the 25th anniversary of our partnership with Bristol Myers Squibb for innovative discovery research in human health.
Development and Manufacturing Services grew by 28% year-on-year. Growth was driven by repeat orders from existing clients as well as an increase in the number of collaborations with emerging biopharma companies.
Total workforce
scientists
PhD scientists
New joinees
Hours of mandatory and technical learning